脂肪肝,肝硬化和肝癌研究 (TENDENCY):一个多中心病例控制研究的协议
Yaqza Hussain1, Ayman Bannaga1, Neil Fisher2
1University Hospitals Coventry & Warwickshire, Coventry, United Kingdom.
JMIR research protocols
|May 31, 2023
概括
这项研究调查了早期肝细胞癌 (HCC) 检测的新型非侵入性生物标志物. 验证甲基化septin 9,挥发性有机化合物和旨在改善肝癌患者的查.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 生物标志物发现发现
- 诊断研究研究 诊断研究
背景情况:
- 肝细胞癌 (HCC) 的死亡率很高,需要改进早期检测方法.
- 目前的HCC查工具,包括α胎蛋白和超声波,具有有限的灵敏度.
- 肝硬化患者,特别是非酒精性脂肪肝和病毒性肝炎患者,患HCC的风险较高.
研究的目的:
- 为了验证肝细胞癌 (HCC) 诊断的新型非侵入性查标志物.
- 评估甲基化隔膜9,尿液挥发性有机化合物和尿液作为潜在的HCC生物标志物.
- 在肝病管理的背景下研究这些生物标志物.
主要方法:
- 采用了一个多中心,嵌套的病例控制研究设计.
- 在HCC病例和肝硬化对照之间比较了血甲基化隔膜蛋白9水平.
- 用先进的光谱技术分析尿液样本以检测HCC特有的挥发性有机化合物和.
主要成果:
- 为TENDENCY研究招募参与者于2023年3月结束.
- 该研究目前正在进行数据分析,预计将于2023年11月完成.
结论:
- 肝细胞癌的有效查测试仍然是一个关键的未满足的需求.
- 敏感的血和尿路生物标志物的整合可以提高早期HCC检测.
- 通过新型生物标志物的提前检测有潜力显著改善HCC患者的治疗结果.
关键词:
肝硬化是肝硬化的一种疾病.脂肪肝是一种脂肪肝.脂肪肝是一种脂肪肝疾病.肝炎肝炎是什么意思 肝炎肝炎是什么意思肝细胞癌是一种肝细胞癌.肝癌 肝癌 是一种肝癌.甲基化隔膜 9 9尿路酸 在尿路酸.尿液中的挥发性有机化合物更多相关视频
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
12.0K
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
3.6K
相关概念视频
Diseases of the Liver and Gallbladder
705
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
705
Chronic Pancreatitis II: Collaborative Care
117
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
117
